Why is it still drug discovery?

EBR - European Biopharmaceutical Review

Volumn , Issue SPRI, 2008, Pages 72-76

  Segall, Matthew ^a  

^a BioFocus DPI   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL STRUCTURE; COMPUTER PROGRAM; DRUG ABSORPTION; DRUG DESIGN; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG INDUSTRY; DRUG METABOLISM; DRUG RESEARCH; DRUG SYNTHESIS; SHORT SURVEY; STRUCTURE ACTIVITY RELATION;

EID: 77958116450     PISSN: 1364369X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (16)

1. Bolten BM and Degregorio T, From the analyst's couch, Trends in development cycles, Nat Rev Drug Discov1: pp335-336, 2002
2. Dimasi JA, Hansen RW and Grabowski HG, The price of innovation: new estimates of drug development costs, J Health Econ 22: pp151-185, 2003
3. Truhlar DG, Howe WJ, Hopfinger AJ, Blaney J and Dammkoehler RE, Rational Drug Design, 1999
4. Veerpandian P, Structure-Based Drug Design, 1997
5. Dean PM, Lloyd DG and Todorov NP, De novo drug design: integration of structure-based and ligand-based methods, Curr Opin Drug Discov Devel 7: pp347-353, 2004
6. Selick HE, Beresford AP and Tarbit MH, The emerging importance of predictive ADME simulation in drug discovery, Drug Discov Today 7: pp109-116, 2002
7. Gardner J, Early Stage Drug Discovery 2004, Combi-Chem & High Throughput Screening Revisited, 2004
8. Guner OF, Pharmacophore Perception, Development, and Use in Drug Design, 2000
9. Jones G, Willett P, Glen RC, Leach AR and Taylor R, Development and validation of a genetic algorithm for flexible docking, J Mol Biol 267: pp727-748, 1997
10. Hansch C and Leo A, Exploring QSAR Volume 1: Fundamentals and Applications in Chemistry and Biology, 1995
11. Van de Waterbeemd H and Gifford E, ADMET in silico modelling: towards prediction paradise? Nat Rev Drug Discov 2: pp192-204, 2003
12. Lipinski CA, Lombardo F, Dominy BW and Feeney PJ, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv Drug Deliv Rev 23: pp3-25, 1997
13. Jones JP, Mysinger M and Korzewka KR, Computational models for cytochrome P450: a predictive electronic model for aromatic oxidation and hydrogen atom abstraction, Drug Metab Dispos 30: pp7-12, 2002
14. Cianchetta G, Li Y, Kang J, Rampe D, Fravolini A, Cruciani G and Vaz RJ: Predictive models for hERG potassium channel blockers, Bioorg Med Chem Lett 15: pp3,637-3,642, 2005
15. Mezrich B, Bringing Down the House: How Six Students Took Vegas for Millions, 2004
16. Segall MD, Beresford AP, Gola JMR, Hawksley D and Tarbit MH, Focus on Success: Using a Probabilistic Approach to Achieve an Optimal Balance of Compound Properties in Drug Discovery, Expert Opin Drug Metab Toxicology, 2: pp325-337, 2006